---
figid: PMC5445606__41531_2016_1_Fig4_HTML
figtitle: Insulin receptor signaling activates proteases for amyloidogenic proteins
organisms:
- NA
pmcid: PMC5445606
filename: 41531_2016_1_Fig4_HTML.jpg
figlink: /pmc/articles/PMC5445606/figure/Fig4/
number: F4
caption: Insulin receptor signaling activates proteases for amyloidogenic proteins.
  A schematic figure showing that insulin receptor signaling pathway targets IDE and
  degrades both insulin and Aβ. Similarly, KLK6 may be regulated by insulin receptor
  signaling pathway to degrade αS
papertitle: Combined immunotherapy with “anti-insulin resistance” therapy as a novel
  therapeutic strategy against neurodegenerative diseases.
reftext: Yoshiki Takamatsu, et al. NPJ Parkinsons Dis. 2017;3:4.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9446884
figid_alias: PMC5445606__F4
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC5445606__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5445606__41531_2016_1_Fig4_HTML.html
  '@type': Dataset
  description: Insulin receptor signaling activates proteases for amyloidogenic proteins.
    A schematic figure showing that insulin receptor signaling pathway targets IDE
    and degrades both insulin and Aβ. Similarly, KLK6 may be regulated by insulin
    receptor signaling pathway to degrade αS
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ab
  - Appl
  - Ide
  - as
  - Akt
---
